Budesonide Extended-Release Capsules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Budesonide Extended-Release Capsules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: budesonide
Brand name: Entocort EC, Uceris, Pulmicort Flexhaler, Pulmicort Respules
Synonyms: Budesonide, Budesonide (Oral Inhalation)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Budesonide Extended-Release Capsules-Insulin degludec
- Budesonide Extended-Release Capsules-Insulin Degludec (U-100) Prefilled Pens
- Budesonide Extended-Release Capsules-Insulin Degludec (U-100) Vials
- Budesonide Extended-Release Capsules-Insulin Degludec (U-200) Prefilled Pens
- Budesonide Extended-Release Capsules-Insulin degludec and liraglutide
- Budesonide Extended-Release Capsules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Budesonide Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Budesonide inhalation
- Insulin aspart, recombinant Subcutaneous-Budesonide Inhalation Powder
- Insulin aspart, recombinant Subcutaneous-Budesonide Inhalation Suspension
- Insulin aspart, recombinant Subcutaneous-Budesonide nasal
- Insulin aspart, recombinant Subcutaneous-Budesonide Nasal Spray